<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Stock Market News &#38; Stocks to Watch from StraightStocks &#187; Immunotherapeutics</title>
	<atom:link href="http://www.straightstocks.com/tag/immunotherapeutics/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.straightstocks.com</link>
	<description>Leading Stock Market News, Opinions and Commentary</description>
	<lastBuildDate>Sat, 20 Mar 2010 14:12:21 +0000</lastBuildDate>
	<generator>http://wordpress.org/?v=2.9.2</generator>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
			<item>
		<title>December 14th CEOcast Weekly Newsletter</title>
		<link>http://www.straightstocks.com/investing-lessons/december-14th-ceocast-weekly-newsletter/</link>
		<comments>http://www.straightstocks.com/investing-lessons/december-14th-ceocast-weekly-newsletter/#comments</comments>
		<pubDate>Mon, 14 Dec 2009 21:18:11 +0000</pubDate>
		<dc:creator>QualityStocks</dc:creator>
				<category><![CDATA[Investing Lessons]]></category>
		<category><![CDATA[Small & Micro Cap]]></category>
		<category><![CDATA[Accenture;]]></category>
		<category><![CDATA[Adobe Systems]]></category>
		<category><![CDATA[Americas Holdings]]></category>
		<category><![CDATA[behavioral healthcare]]></category>
		<category><![CDATA[Best Buy]]></category>
		<category><![CDATA[Biotechnology]]></category>
		<category><![CDATA[cancer]]></category>
		<category><![CDATA[cancer prevention]]></category>
		<category><![CDATA[Cancers]]></category>
		<category><![CDATA[Capstone facility]]></category>
		<category><![CDATA[Carnival Cruise Lines]]></category>
		<category><![CDATA[Catasys]]></category>
		<category><![CDATA[CellOptics]]></category>
		<category><![CDATA[CellOptics platform]]></category>
		<category><![CDATA[cent;]]></category>
		<category><![CDATA[chief]]></category>
		<category><![CDATA[China]]></category>
		<category><![CDATA[cholesterol lowering product]]></category>
		<category><![CDATA[cloud storage networks]]></category>
		<category><![CDATA[Cohava Gelber;]]></category>
		<category><![CDATA[Colonel]]></category>
		<category><![CDATA[Constantine Ioannides]]></category>
		<category><![CDATA[Consumer Finance]]></category>
		<category><![CDATA[Core]]></category>
		<category><![CDATA[Denver]]></category>
		<category><![CDATA[deputy director]]></category>
		<category><![CDATA[Detroit]]></category>
		<category><![CDATA[Director of the Cancer Vaccine Development Program]]></category>
		<category><![CDATA[Discover Financial Services;]]></category>
		<category><![CDATA[electronic medical record systems]]></category>
		<category><![CDATA[energy supplements]]></category>
		<category><![CDATA[Enzo Biochem]]></category>
		<category><![CDATA[Enzo Clinical Labs]]></category>
		<category><![CDATA[evidence-based nutritional solutions]]></category>
		<category><![CDATA[Fed Ex]]></category>
		<category><![CDATA[Federal Reserve System]]></category>
		<category><![CDATA[Forbes Medi-Tech Inc.]]></category>
		<category><![CDATA[Ford Motor Company]]></category>
		<category><![CDATA[glioblastoma;]]></category>
		<category><![CDATA[H. Pixel International Trade Ltd.]]></category>
		<category><![CDATA[health and security identification tools]]></category>
		<category><![CDATA[health care products]]></category>
		<category><![CDATA[Health Network]]></category>
		<category><![CDATA[Healthcare Services]]></category>
		<category><![CDATA[Hythiam]]></category>
		<category><![CDATA[Iceweb]]></category>
		<category><![CDATA[Ikonisys Inc.]]></category>
		<category><![CDATA[ImmunoCellular Therapeutics]]></category>
		<category><![CDATA[Immunotherapeutics]]></category>
		<category><![CDATA[integrated biotechnology;]]></category>
		<category><![CDATA[interactive media company specializing]]></category>
		<category><![CDATA[Iplicity Unified Storage Platform]]></category>
		<category><![CDATA[israel]]></category>
		<category><![CDATA[Las Vegas]]></category>
		<category><![CDATA[M.D.]]></category>
		<category><![CDATA[Michigan]]></category>
		<category><![CDATA[Morgan Stanley]]></category>
		<category><![CDATA[New Jersey]]></category>
		<category><![CDATA[New York]]></category>
		<category><![CDATA[Next One Interactive]]></category>
		<category><![CDATA[Nike]]></category>
		<category><![CDATA[no-charge software]]></category>
		<category><![CDATA[nutrition retail locations]]></category>
		<category><![CDATA[One Bio]]></category>
		<category><![CDATA[Oracle]]></category>
		<category><![CDATA[Organic Products]]></category>
		<category><![CDATA[Palm Beaches]]></category>
		<category><![CDATA[philadelphia fed]]></category>
		<category><![CDATA[Pioneer Behavioral Health]]></category>
		<category><![CDATA[PositiveID Corp]]></category>
		<category><![CDATA[Professor of Immunology]]></category>
		<category><![CDATA[raw chemicals]]></category>
		<category><![CDATA[Raymond James]]></category>
		<category><![CDATA[Reducol]]></category>
		<category><![CDATA[Research-In-Motion]]></category>
		<category><![CDATA[Resort & Residence TV]]></category>
		<category><![CDATA[Rite Aid]]></category>
		<category><![CDATA[San Francisco]]></category>
		<category><![CDATA[Sanming City]]></category>
		<category><![CDATA[Scientific Advisory Board;]]></category>
		<category><![CDATA[Seven Hills Behavioral Institute]]></category>
		<category><![CDATA[Southeast Asia]]></category>
		<category><![CDATA[Southern Florida Regional Heath Information Organization]]></category>
		<category><![CDATA[Sparta Commercial Services]]></category>
		<category><![CDATA[substance dependence]]></category>
		<category><![CDATA[substance dependence solution]]></category>
		<category><![CDATA[Technology Officer]]></category>
		<category><![CDATA[The Philippines]]></category>
		<category><![CDATA[Therapeutic Products]]></category>
		<category><![CDATA[travel industry organizations]]></category>
		<category><![CDATA[travel offers]]></category>
		<category><![CDATA[travel shopping show]]></category>
		<category><![CDATA[treatment of brain and other cancers]]></category>
		<category><![CDATA[United States Military Cancer Institute]]></category>
		<category><![CDATA[USD]]></category>
		<category><![CDATA[Weight Management]]></category>

		<guid isPermaLink="false">http://Blog.QualityStocks.net/?p=19860</guid>
		<description><![CDATA[Companies featured in this edition of the newsletter: DKAM, ENZ, FMTI, HYTM, IMUC, IWEB, NXOI, ONBI, PHC, PSID, SRCO
Markets finished this relatively quiet week much where they began, as a lack of significant catalysts left markets trading mostly sideways and led to the major indices closing decidedly mixed following the week&#8217;s activities. All told, the [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/investing-lessons/december-14th-ceocast-weekly-newsletter/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Hemispherx Biopharma, Inc. (HEB) is “One to Watch”</title>
		<link>http://www.straightstocks.com/investing-lessons/hemispherx-biopharma-inc-heb-is-%e2%80%9cone-to-watch%e2%80%9d/</link>
		<comments>http://www.straightstocks.com/investing-lessons/hemispherx-biopharma-inc-heb-is-%e2%80%9cone-to-watch%e2%80%9d/#comments</comments>
		<pubDate>Fri, 04 Dec 2009 15:35:28 +0000</pubDate>
		<dc:creator>QualityStocks</dc:creator>
				<category><![CDATA[Investing Lessons]]></category>
		<category><![CDATA[Small & Micro Cap]]></category>
		<category><![CDATA[Alferon N Injection]]></category>
		<category><![CDATA[Biopharmaceutical]]></category>
		<category><![CDATA[commercialized product]]></category>
		<category><![CDATA[Hemispherx Biopharma Inc.;]]></category>
		<category><![CDATA[immune-based disorders]]></category>
		<category><![CDATA[Immunotherapeutics]]></category>
		<category><![CDATA[Infectious Diseases]]></category>
		<category><![CDATA[Influenza]]></category>
		<category><![CDATA[National Institute of Infectious Diseases]]></category>
		<category><![CDATA[pharma products]]></category>
		<category><![CDATA[Platform Technology]]></category>
		<category><![CDATA[Princess Margaret Hospital]]></category>
		<category><![CDATA[Tokyo]]></category>
		<category><![CDATA[United States]]></category>
		<category><![CDATA[USD]]></category>
		<category><![CDATA[viral infections]]></category>

		<guid isPermaLink="false">http://Blog.QualityStocks.net/?p=19687</guid>
		<description><![CDATA[Hemispherx Biopharma, Inc. (AMEX: HEB) is a biopharmaceutical company focused on the manufacture and clinical development of new drug entities designed to treat viral and immune-based disorders.  Hemispherx’s flagship products include Alferon N Injection® and the experimental immunotherapeutics/antivirals Ampligen® and Oragens®.  
The company’s platform technology includes large and small agent components for potential [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/investing-lessons/hemispherx-biopharma-inc-heb-is-%e2%80%9cone-to-watch%e2%80%9d/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>TapImmune, Inc. (TPIV.OB) Among the Winners in the Booming Vaccine Business</title>
		<link>http://www.straightstocks.com/investing-lessons/tapimmune-inc-tpiv-ob-among-the-winners-in-the-booming-vaccine-business/</link>
		<comments>http://www.straightstocks.com/investing-lessons/tapimmune-inc-tpiv-ob-among-the-winners-in-the-booming-vaccine-business/#comments</comments>
		<pubDate>Tue, 24 Nov 2009 14:55:15 +0000</pubDate>
		<dc:creator>QualityStocks</dc:creator>
				<category><![CDATA[Investing Lessons]]></category>
		<category><![CDATA[Small & Micro Cap]]></category>
		<category><![CDATA[AdhTAP]]></category>
		<category><![CDATA[Antigen Processing]]></category>
		<category><![CDATA[antigen processing machinery]]></category>
		<category><![CDATA[antigen processing pathway]]></category>
		<category><![CDATA[Biotechnology]]></category>
		<category><![CDATA[biotechnology company specializing]]></category>
		<category><![CDATA[cancer]]></category>
		<category><![CDATA[Cancer Therapy]]></category>
		<category><![CDATA[Immunotherapeutics]]></category>
		<category><![CDATA[Infectious Disease]]></category>
		<category><![CDATA[Infectious Diseases]]></category>
		<category><![CDATA[lead product candidate]]></category>
		<category><![CDATA[Pharmaceutical Industry]]></category>
		<category><![CDATA[Swine Flu;]]></category>
		<category><![CDATA[TAP technology]]></category>
		<category><![CDATA[TapImmune Inc.]]></category>
		<category><![CDATA[treating cancer]]></category>
		<category><![CDATA[vaccine technology]]></category>
		<category><![CDATA[Vaccines]]></category>

		<guid isPermaLink="false">http://Blog.QualityStocks.net/?p=19493</guid>
		<description><![CDATA[
Recent headlines swirling around the swine flu have centered the focus of both the public and investors on vaccines and the vaccine industry. The vaccine marketplace is expected to show big gains through 2012 as it emerges as one of the most lucrative sectors of the global pharmaceutical industry. This bodes well for innovative companies [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/investing-lessons/tapimmune-inc-tpiv-ob-among-the-winners-in-the-booming-vaccine-business/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>TapImmune, Inc. (TPIM.OB) Lead Product Receives Medical Attention</title>
		<link>http://www.straightstocks.com/current-market-news/tapimmune-inc-tpimob-lead-product-receives-medical-attention/</link>
		<comments>http://www.straightstocks.com/current-market-news/tapimmune-inc-tpimob-lead-product-receives-medical-attention/#comments</comments>
		<pubDate>Tue, 03 Jun 2008 21:20:16 +0000</pubDate>
		<dc:creator>QualityStocks</dc:creator>
				<category><![CDATA[Current Market News]]></category>
		<category><![CDATA[OTCBB Markets]]></category>
		<category><![CDATA[Small & Micro Cap]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[Antigen Processing]]></category>
		<category><![CDATA[biotech]]></category>
		<category><![CDATA[Biotechnology Company]]></category>
		<category><![CDATA[Cancer Cells]]></category>
		<category><![CDATA[Cancer Markers]]></category>
		<category><![CDATA[Cancer Therapy]]></category>
		<category><![CDATA[Cancerous Cells]]></category>
		<category><![CDATA[Clinical Evaluation]]></category>
		<category><![CDATA[Immunotherapeutics]]></category>
		<category><![CDATA[Infectious Diseases]]></category>
		<category><![CDATA[Initial Description]]></category>
		<category><![CDATA[Journal Of Investigative Dermatology]]></category>
		<category><![CDATA[Malignant Melanoma]]></category>
		<category><![CDATA[Medical Attention]]></category>
		<category><![CDATA[Otcbb]]></category>
		<category><![CDATA[Research Article]]></category>
		<category><![CDATA[Rogue Cells]]></category>
		<category><![CDATA[S Trading]]></category>
		<category><![CDATA[Treatment Of Cancer]]></category>
		<category><![CDATA[Tumor Recognition]]></category>
		<category><![CDATA[Viral Antigens]]></category>

		<guid isPermaLink="false">http://Blog.QualityStocks.net/?p=10447</guid>
		<description><![CDATA[TapImmune, Inc. (OTCBB: TPIM) announced that their TAP incorporated vaccine for the treatment of cancer was recently reviewed by a third party research article in the Journal of Investigative Dermatology, which confirmed that the company&#8217;s vaccine should be considered as a therapy for cancer.  
The article, entitled, &#8220;Restoration of the Expression of Transporters Associate [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/current-market-news/tapimmune-inc-tpimob-lead-product-receives-medical-attention/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>
